Open access
Jul 2026
Clinical outcomes with a fixed-dose combination of oral Montelukast and Acebrophylline in bronchial asthma: a prospective, single-arm clinical study.
The findings demonstrate that the FDC of montelukast and acebrophylline has a favorable safety profile and is associated with improvements in lung function and asthma symptoms.
Rakhi Ludam, Mayank Agrawal, K. M. Patel et al.
· Journal of Asthma · 0 citations